Vancomycin and linear IgA bullous dermatosis

  • Amr Ismail Departments of Internal Medicine at Texas Tech University Health Sciences Center, Lubbock, TX
  • Rocio Gavidia Quezada Departments of Internal Medicine at Texas Tech University Health Sciences Center, Lubbock, TX
  • Kenneth Iwuji Departments of Internal Medicine at Texas Tech University Health Sciences Center, Lubbock, TX
  • Abdussalam Shredi Departments of Internal Medicine at Texas Tech University Health Sciences Center, Lubbock, TX
  • Michelle Tarbox Dermatology at Texas Tech University Health Sciences Center, Lubbock, TX
DOI: https://doi.org/10.12746/swrccc.v6i22.445

Abstract

Vancomycin is a broad-spectrum antibiotic that is considered an optimal parenteral treatment for many infections, including septicemia, pneumonia, cellulitis, endocarditis, and meningitis caused by methicillin-resistant Staphylococcus aureus. It is the first-line treatment for the increasing health care-associated infection Clostridium difficile pseudomembranous colitis. More side effects are being reported secondary to increased vancomycin use. Of those side effects, skin reactions are becoming more recognized by physicians.

Keywords: Vancomycin, methicillin-resistant Staphylococcus aureus, linear IgA bullous dermatosis, vancomycin skin reactions

Downloads

Download data is not yet available.

References

VISA/VRSA–Vancomycin–Intermediate/Resistant Staphylococcus

aureus fact sheet. Available at: http://www.cdc.gov/

ncidod/hip/ARESIST/visa.htm.

Korman TM, Turnidge JD, Grayson ML. Risk factors for

adverse cutaneous reactions associated with intravenous vancomycin.

J Antimicrob Chemother 1997;39:315–318.

Jones DH. Early diagnosis is key in vancomycin-induced linear

IgA bullous dermatosis and Stevens-Johnson syndrome. J

Am Osteopath Assoc 2004 Apr; 104(4):157–63.

Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous

dermatosis. Clin Dermatol 2012;30:38.

Minhas JS, Immune-mediated reactions to vancomycin: A

systematic case review and analysis. Ann Allergy Asthma

Immunol 2016 Jun 4; 116(6):544–53.

Lings K, Bygum A. Linear IgA bullous dermatosis: a retrospective

study of 23 patients in Denmark. Acta Derm Venereol

;95:466–471.

Published
2018-01-19
How to Cite
Ismail, A., Quezada, R. G., Iwuji, K., Shredi, A., & Tarbox, M. (2018). Vancomycin and linear IgA bullous dermatosis. The Southwest Respiratory and Critical Care Chronicles, 6(22), 38-41. https://doi.org/10.12746/swrccc.v6i22.445
Issue
Vol 6 No 22 (2018): The Southwest Respiratory and Critical Care Chronicles
Section
Case Reports
Crossref
Scopus
Google Scholar
Europe PMC